Novare Capital Management’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-66,739
| Closed | -$5.97M | – | 157 |
|
|
2018
Q3 | $5.97M | Buy |
66,739
+10,470
| +19% | +$937K | 0.95% | 44 |
|
|
2018
Q2 | $4.47M | Buy |
56,269
+510
| +0.9% | +$40.5K | 0.76% | 55 |
|
|
2018
Q1 | $4.97M | Buy |
55,759
+3,715
| +7% | +$331K | 0.87% | 48 |
|
|
2017
Q4 | $5.43M | Buy |
52,044
+3,265
| +7% | +$341K | 0.92% | 42 |
|
|
2017
Q3 | $7.11M | Buy |
48,779
+260
| +0.5% | +$37.9K | 1.25% | 20 |
|
|
2017
Q2 | $6.3M | Buy |
48,519
+275
| +0.6% | +$35.7K | 1.42% | 27 |
|
|
2017
Q1 | $6M | Buy |
48,244
+345
| +0.7% | +$42.9K | 1.39% | 26 |
|
|
2016
Q4 | $5.54M | Buy |
47,899
+5,195
| +12% | +$601K | 1.36% | 26 |
|
|
2016
Q3 | $4.46M | Buy |
42,704
+23,435
| +122% | +$2.45M | 1.17% | 38 |
|
|
2016
Q2 | $1.9M | Buy |
19,269
+14,909
| +342% | +$1.47M | 0.51% | 72 |
|
|
2016
Q1 | $436K | Sell |
4,360
-10,370
| -70% | -$1.04M | 0.12% | 93 |
|
|
2015
Q4 | $1.76M | Hold |
14,730
| – | – | 0.48% | 66 |
|
|
2015
Q3 | $1.59M | Hold |
14,730
| – | – | 0.44% | 70 |
|
|
2015
Q2 | $1.71M | Sell |
14,730
-200
| -1% | -$23.2K | 0.42% | 68 |
|
|
2015
Q1 | $1.72M | Buy |
14,930
+40
| +0.3% | +$4.61K | 0.43% | 66 |
|
|
2014
Q4 | $1.67M | Sell |
14,890
-300
| -2% | -$33.6K | 0.41% | 69 |
|
|
2014
Q3 | $1.44M | Sell |
15,190
-6,930
| -31% | -$657K | 0.35% | 74 |
|
|
2014
Q2 | $1.9M | Hold |
22,120
| – | – | 0.46% | 69 |
|
|
2014
Q1 | $1.54M | Hold |
22,120
| – | – | 0.41% | 72 |
|
|
2013
Q4 | $1.87M | Hold |
22,120
| – | – | 0.52% | 68 |
|
|
2013
Q3 | $1.71M | Buy |
22,120
+120
| +0.5% | +$9.25K | 0.53% | 67 |
|
|
2013
Q2 | $1.29M | Buy |
+22,000
| New | +$1.29M | 0.43% | 71 |
|